Protagenic Therapeutics, Inc. PTIX
0.51 USD 0.00 (+0.00%)
Nov 11, 2026, 11:02 AM EST
0.51 Day range 0.51
0.128 52-week range 2.38
- YTD
- -60.77%
- 1 year
- -73.02%
News
benzinga.com Protagenic Therapeutics Reports Topline Phase 1 Safety Data For PT00114, Was Well Tolerated Across All Dose Ranges Studied; Paves Way For Phase 2 In Stress-Related Neuropsychiatric Conditions Findings support advancement into Phase 2 to explore a first-in-class pathway aimed at stress-related neuropsychiatric conditionsNEW YORK CITY, NEW YORK / ACCESS Newswire / December 9, 2025 /…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Protagenic Therapeutics Completes Enrollment, Dosing In Its Multiple Ascending Dose Phase 1 Trial Evaluating PT00114 Protagenic Therapeutics Inc. (NASDAQ:PTIX), a biopharmaceutical company developing novel therapeutics for stress-related neuropsychiatric and neurodegenerative disorders, today announced the…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
benzinga.com Protagenic Therapeutics Expects To File Its Quarterly Report On Form 10-Q For The Period Ended June 30, 2025 In The Near Future, Following A Delay Attributable To The Completion Of Merger-Related Consolidation Of Financial Statements, Including Purchase Accounting Adjustments, Pro Forma Financial Information, And Related Disclosures NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a biopharmaceutical company developing novel neuro-active peptide therapies, today announced that it…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress Shares of Protagenic Therapeutics are trading sharply higher Thursday afternoon. The stock soared over 100% midday after the company announced a key clinical milestone.
benzinga.com S&P 500 Moves Lower; Walmart Shares Fall After Q2 Results - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Dow Dips Over 100 Points; US Initial Jobless Claims Increase 
benzinga.com Protagenic Completes First Dose Injections In Phase I Multiple-Dose Study Of PT00114; Topline Safety Data Expected By September; Phase 2 Launch Targeted For Q1 2026 Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026NEW YORK, NY / ACCESS Newswire / August 21, 2025 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a…
benzinga.com Protagenic Therapeutics Announces Major Restructuring: Transitions To Virtual Operating Model, Cuts $8M In Annual Costs, Halts Preclinical Programs, Terminates CEO And COO, Changes Fiscal Year-End, And Refocuses On Lead Clinical Trial For PT00114 Item 2.05 Costs Associated with Exit or Disposal Activities. On August 8, 2025, the Board of Directors (the "Board") of Protagenic Therapeutics, Inc. (the "Company" or "Protagenic") approved a…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Nasdaq Falls 100 Points; Home Depot Sales Top Views 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket 
benzinga.com Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Protagenic Therapeutics (PTIX) Stock Soars 240% On Phytanix Merger Protagenic Therapeutics shares soared 240% Monday on its all-stock merger with Phytanix Bio. New Phytanix targets CNS disorders with an expanded diverse pipeline and experienced team.
benzinga.com Dow Tumbles 200 Points; ZIM Integrated Shipping Services Posts Upbeat Earnings 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session - benzinga.com As Calculated On A Fully Diluted Basis, Post-Combination Pre-Financing Ownership Will Be Approximately 35% For The Pre-Combination Stockholders Of The Company And Approximately 65% For Phytanix Bio Stockholders. Structure of CombinationUnder the terms of the Exchange Agreement, the Company, in exchange for all of the outstanding shares of Phytanix Bio, issued on a pro rata basis to each of the common…
benzinga.com Why Quantum Computing Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - benzinga.com Protagenic Therapeutics Q1 EPS $(2.75) Up From $(5.44) YoY Protagenic Therapeutics (NASDAQ:PTIX) reported quarterly losses of $(2.75) per share. This is a 49.45 percent increase over losses of $(5.44) per share from the same period last year.
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March - benzinga.com 11 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com Protagenic Therapeutics Announces Pricing Of $1.275M Private Placement For The Purchase And Sale Of An Aggregate Of 1,948,295 Shares Of Common Stock; The Purchase Price Of Each Share Of Common Stock And Associated Common Stock Purchase Warrants Will Be $0.64 Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, announced today it has entered into a purchase agreement (the…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session